Skip to main content

Quality Care

By HIMSS TV | 11:14 am | December 16, 2024
Rami Karjian, head of the operating rooms business at LeanTaaS, says 17% of healthcare providers had to delay or cancel surgeries, which has a huge impact on patients, on the finances of a hospital and on caregivers who have to make up for the backlog.
By Jessica Hagen | 01:33 pm | December 12, 2024
Industry executives share their thoughts on the year's digital health developments - from an increased focus on women’s health to the rise of generative AI.
By Jessica Hagen | 10:00 am | December 12, 2024
Tuva's CEO told MobiHealthNews that the company operates by "open-sourcing" the specialized knowledge needed to transform healthcare data and embedding that knowledge into an analytics-ready data model.
By Jessica Hagen | 12:43 pm | December 11, 2024
The funding comes more than a year after the company closed an oversubscribed $31.4 million Series B round.
By Jessica Hagen | 01:39 pm | December 10, 2024
The Series B extension brings the round to $35 million, raising Hyro's total funding to $50 million.
By Anthony Vecchione | 10:35 am | December 10, 2024
Sameer Sethi, senior vice president and chief AI and insights officer at Hackensack Meridian Health joined MobiHealthNews to discuss the health system's plans for AI spending in 2025.   
By HIMSS TV | 10:27 am | December 10, 2024
Andre Esteva, CEO and cofounder of Artera, a spin-out of Salesforce, relays how the company's AI tool looks at images of cancer tumors and recommends specific therapies to clinicians.
By Jessica Hagen | 12:43 pm | December 06, 2024
The company aims to empower physicians with job transparency, financial tools and a peer community to enhance workplace fulfillment and autonomy.
By Jessica Hagen | 07:12 pm | December 03, 2024
The integration will give long-term and post-acute care providers access to tools designed to improve patient outcomes and streamline care management.
By Anthony Vecchione | 02:31 pm | December 03, 2024
The company will use the funds to support its ongoing clinical trial, ramp up production and sales for its OtoSight Middle Ear Scope and relocate its headquarters.